Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #176

Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy

If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month period.

Submission Methods: Registry
Measure Sets: Dermatology, Family Medicine, Infectious Disease, Internal Medicine, Rheumatology

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.